Literature DB >> 11207544

Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage.

R Zarrilli1, V Ricci, M Romano.   

Abstract

Infection with the Gram-negative bacterium Helicobacter pylori leads to different clinical and pathological outcomes in humans, including chronic gastritis, peptic ulcer disease and adenocarcinoma of the stomach. H. pylori-induced damage to gastric mucosal cells is controlled by bacterial virulence factors encoded by genes of the cag pathogenicity island, which trigger the inflammatory response of the host through the activation of nuclear factor kappaB-dependent gene transcription. Also, H. pylori infection impairs the processes of gastric mucosal healing through inhibition of epidermal growth factor receptor-dependent signal transduction pathways and induction of apoptosis. H. pylori infection may influence the progression from chronic gastritis to gastric adenocarcinoma by stimulating cell proliferation and growth factor expression, inhibiting apoptosis and increasing the DNA mutation rate of infected gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11207544     DOI: 10.1046/j.1462-5822.1999.00018.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  23 in total

Review 1.  Eradication of Helicobacter pylori: a clinical update.

Authors:  Marco Romano; Antonio Cuomo
Journal:  MedGenMed       Date:  2004-02-17

2.  Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype.

Authors:  G Le'Negrate; V Ricci; V Hofman; B Mograbi; P Hofman; B Rossi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes.

Authors:  Michael Fehlings; Lea Drobbe; Verena Moos; Pablo Renner Viveros; Jana Hagen; Macarena Beigier-Bompadre; Ervinna Pang; Elena Belogolova; Yuri Churin; Thomas Schneider; Thomas F Meyer; Toni Aebischer; Ralf Ignatius
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

4.  High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin.

Authors:  Maribel Rodríguez-Torres; Rosa Salgado-Mercado; Carlos F Ríos-Bedoya; Edgardo Aponte-Rivera; Acisclo M Marxuach-Cuétara; José F Rodríguez-Orengo; Alberto Fernández-Carbia
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

5.  In vivo and in vitro studies of cytosolic phospholipase A2 expression in Helicobacter pylori infection.

Authors:  G Nardone; E L Holicky; J R Uhl; L Sabatino; S Staibano; A Rocco; V Colantuoni; B A Manzo; M Romano; G Budillon; F R Cockerill; L J Miller
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 6.  Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Authors:  Aline Cristina Targa Cadamuro; Ana Flávia Teixeira Rossi; Nathália Maciel Maniezzo; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 7.  H. pylori infection, inflammation and gastric cancer.

Authors:  Qurteeba Qadri; Roohi Rasool; G M Gulzar; Sameer Naqash; Zafar A Shah
Journal:  J Gastrointest Cancer       Date:  2014-06

8.  Effect of jianpiyiwei capsule on gastric precancerous lesions in rats.

Authors:  Xue-Ying Shi; Feng-Zhi Zhao; Xin Dai; Lian-Sheng Ma; Xiu-Yu Dong; Jie Fang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  Helicobacter pylori induces apoptosis of human monocytes but not monocyte-derived dendritic cells: role of the cag pathogenicity island.

Authors:  Mario Galgani; Immacolata Busiello; Stefano Censini; Serafino Zappacosta; Luigi Racioppi; Raffaele Zarrilli
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Abnormal growth factor/cytokine network in gastric cancer.

Authors:  Eiichi Tahara
Journal:  Cancer Microenviron       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.